In a landscape where lung cancer remains one of the most challenging diseases to treat, particularly for rare subsets of patients, a new development has sparked hope among clinicians and affected individuals alike. Bayer’s recently approved drug, sevabertinib, marketed as Hyrnuo, has gained
In the intricate world of drug development, where every trial holds the potential to transform lives, a quiet revolution is unfolding in the unassuming spaces of suburban medical corridors, reshaping how research reaches communities. Outpatient clinics, traditionally viewed as mere venues for
What happens when the building blocks of life face destruction before they can fulfill their purpose, and how do cells protect these vital components during such a delicate process? Inside every cell, a precise mechanism unfolds where proteins, essential for everything from immunity to growth, are
Could a machine hold the key to ending one of humanity’s most persistent health crises? At Scripps Research, a staggering $1.1 million investment in artificial intelligence (AI) is igniting a new chapter in the fight against HIV, a virus that continues to impact over 40 million people worldwide.
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with a wealth of experience in research and development, as well as a keen understanding of technological innovation in the industry. Today, we’re diving into the recent developments surrounding Agios Pharmaceuticals and their
In a groundbreaking development for rheumatoid arthritis treatment, Lifordi Immunotherapeutics, a clinical-stage biotech firm headquartered in Burlington, Massachusetts, has successfully raised $112 million in a funding round led by Sanofi Ventures, with continued support from prominent investors
